Training Example: Omnipod – Review the Data, Give Your Score & Compare to the Real AI Evaluation

[H1] Set yourself free with Omnipod

[H5] The #1 prescribed insulin pump1

[IMG: Omnipod 5]

[IMG: Omnipod 5]

Pod shown without the necessary adhesive

[H2] Simplicity
Omnipod 5 is a small device that users agree is easy to use§, and delivers insulin without daily injections or annoying tubes that get in the way of everyday life.
[H2] Control
Shown to lower A1c and improved time in range by 22%, automated insulin adjustments with Omnipod 5 help keep you in range day and night.2-5
[H2] Freedom
Trusted by hundreds of thousands of people to simplify their diabetes management, and make space for living life on their own terms.

[H2] A tubeless triumph
One waterproof* Pod gives you up to 3 days (72 hours) of continuous insulin delivery. And the best part? There's no need to disconnect for everyday activities, making it the perfect sidekick to your adventures.Just ask Dyasonic: Born from a groundbreaking collaboration between Omnipod and Marvel, Dyasonic is the bold new hero at the heart of a custom Marvel comic created to celebrate representation for the diabetes community.With the Omnipod 5 on her arm, Dyasonic discovers a powerful truth: when her glucose levels are in range, she can take on anything, and anyone.Meet Dyasonic
*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM (Personal Diabetes Manager) and Controller are not waterproof.

[IMG: Comic book cover image of Marvel and Omnipod]

[IMG: Comic book cover image of Marvel and Omnipod]

[H2] Taking your insulin just got simpler
One waterproof* Pod gives you up to 3 days (72 hours) of continuous insulin delivery for diabetes management that goes where you do. And the best part? There's no need to disconnect for everyday activities.
* The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM (Personal Diabetes Manager) and Controller are not waterproof.

[H2] Which Omnipod is right for you?
Omnipod products were made for people with insulin-requiring diabetes, with options that fit your unique needs.

[IMG: Omnipod Podder, with a Pod on their stomach, on a paddle board on the waters]

[IMG: Omnipod Podder, with a Pod on their stomach, on a paddle board on the waters]

[H2] Type 1 diabetes
Type 1 diabetes doesn’t take a break. But managing your insulin therapy with Omnipod can give you one. Omnipod 5 is indicated for people with type 1 diabetes, ages 2+.
Omnipod for Type 1

[IMG: Couple with dog]

[IMG: Couple with dog]

[H2] Type 2 diabetes (insulin-requiring)
If you feel like type 2 diabetes is taking control of your life, here’s your chance to take it back. Omnipod 5 is indicated for adults with type 2 diabetes, ages 18+.
Omnipod for Type 2

[IMG: mom holding and smiling at daughter who is wearing a pod on her arm]

[IMG: mom holding and smiling at daughter who is wearing a pod on her arm]

[H2] Kids with diabetes
Caring for a child with diabetes is an important job. As a caregiver, you want to choose an insulin delivery method that addresses your child’s evolving health needs while also granting them the freedom to just be a kid.
Omnipod for Kids

[H2] What others say about Omnipod

I feel like it’s part of me and wants me to be the best I can be.

Morgan M.
Podder since 2009

I have the freedom to do everything I did before I went on insulin.

John H.
Sponsored Podvocate
Podder since 2019

It helps me feel like a normal kid, just with a little bit of help.

Romey T.
Sponsored Omnipod® User
& Podder since 2019

Image
[IMG: Podvocate John H.]
"I have the freedom to do everything I did before I went on insulin.”John H. Sponsored Podvocate Podder since 2019

[IMG: Omnipod POD no adhesive]

[IMG: Omnipod POD no adhesive]

Pod shown without the necessary adhesive

[H2] Get started for as little as $0 per month
Most Omnipod 5 customers pay less than $30 per month† at the pharmacy, with more than one third paying $0 out of pocket.‡ You may even be eligible for a free trial.**
Check My Coverage

1. USA 2024, Data on file2. Brown S. et al. Diabetes Care (2021). Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average A1c in adults/adolescents and children, standard therapy vs. Omnipod 5 = 7.16% vs 6.78%; 7.67% vs 6.99%. Average time with high blood glucose in adults/adolescents and children, standard therapy vs 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Average time with low blood glucose in adults/adolescents and children, standard therapy vs 3-month Omnipod 5: 2.9% vs. 1.3%; 2.2% vs. 1.8%.     3. Sherr JL, et al. Diabetes Care (2022). Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average A1c in standard therapy vs. Omnipod 5 = 7.4% vs. 6.9%. Average time with high blood glucose in very young children, standard therapy vs 3-month Omnipod 5: 39.4% vs. 29.5%. Average time with low blood glucose in very young children, standard therapy vs 3-month Omnipod 5: 3.43% vs. 2.46%. Study funded by Insulet.    4. Pasquel FJ, et al. JAMA Network Open (2025). Prospective pivotal trial in 305 participants with T2D aged 18-75 yrs. Study included a 14-day standard therapy (ST) phase followed by a 13-week Omnipod 5 hybrid closed-loop phase. Mean HbA1c: ST vs. 13-week Omnipod 5: 8.2% vs. 7.4%, P<0.001. Mean time >180 mg/dL as measured by CGM: ST = 54%, 3-mo Omnipod 5 = 34%, P<0.001. Mean time <70 mg/dL as measured by CGM: ST = 0.2%, 3-mo Omnipod 5 = 0.2%.5. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) [51% HbA1c≥ 8% (64 mmol/mol)] with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Time in range (70-180 mg/dL or 3.9-10mmol/L) with OP5 improved by 22% (43% MDI vs. 65% OP5, p<0.001). Time below range (<70 mg/dL or <3.9mmol/L) with OP5 was non-inferior to MDI (2.27% MDI vs. 2.56%, p=0.2). Data on file. 2025. RF-042025-00015. §Insulet Data on File. OP5-003 Clinical Study Report. 2024.13-week randomized, parallel-group clinical trial conducted among 194 adults (age 18-70) with type 1 diabetes in France and the U.S., comparing the safety and effectiveness of the Omnipod 5 System versus pump therapy with CGM.†Majority defined as at least 50% of patient co-pays $30 or less per month. Among All Paid Omnipod 5 G7G6 Pods Commercial and Medicare Claims from January 2024 to December 2024. Includes benefits and offerings available through Insulet, such as the copay card program. Actual co-pay amount depends on patient’s health plan and coverage, they may fluctuate and be higher or lower than the advertised amount on a monthly basis. Source: IQVIA OPC Library‡$0 per month claim calculated based on cost for consumption of ten (10) Pods per month. Among All Paid Omnipod 5 G7G6 Pods Commercial and Medicare Claims from January 2024 to December 2024. Includes benefits and offerings available through Insulet, such as the copay card program. Actual co-pay amount depends on patient’s health plan and coverage, they may fluctuate and be higher or lower than the advertised amount on a monthly basis. Source: IQVIA OPC Library.

**Omnipod® 5 Intro Kit 30-Day TrialTerms and Conditions

1. Program EligibilityEligibility criteria: Subject to program limitations and terms and conditions, the Omnipod 5 Intro Kit 30-day trial program (the “Program”) is open to patients who have a valid Omnipod 5 prescription as well as a compatible CGM prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. In order to be eligible, the patient’s eligible insurance plan must include coverage for Omnipod 5 Pods. The Program is open to new Pod Therapy patients coming from multiple daily injections or tubed pumps only who have not previously used Omnipod 5, Omnipod DASH® or Omnipod Insulin Management System.This offer is not valid for participants whose Omnipod 5 or compatible CGM prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs. It is not valid for cash-paying participants or where prohibited by law. A participant is considered cash-paying where the participant has no insurance coverage for Omnipod 5 or where the participant has commercial or private insurance but Insulet determines in its sole discretion the participant is effectively uninsured because such coverage does not provide a material level of financial assistance for the cost of an Omnipod 5 prescription. Participants on certain commercial insurance plans may not be eligible. This offer is only valid in the United States, Puerto Rico, and the U.S. territories. Participants receiving their products through the Durable Medical Equipment or Pharmacy Durable Medical Equipment channel are not eligible to participate in the copay card program. Please contact Insulet Customer Support at 1-800-591-3455 for details.2. Program DetailsWith this program, Participants may be eligible to receive a limited supply of Omnipod 5 products at no cost for them. Eligible participants have two (2) options, based on the following:• A participant shall sign the Omnipod® 5 Intro Kit 30-Day Trial Acknowledgement through the appropriate platform provided by Insulet.• Once Insulet has received the request, the request shall be escalated to Insulet’s pharmacy partner, where a request for a prescription shall be sent to the participant’s healthcare professional. If a valid prescription is received, both for the Omnipod 5 Intro Kit and the Omnipod 5 Pods, the participant’s benefits will be checked by Insulet or its partners.  • IF the benefits check results in a monthly copay equal to or below two hundred dollars ($200), then Insulet shall issue a one-time only copay card to the participant, for a value equal to the out-of-pocket expenses the participant would have to pay for an Omnipod 5 Intro Kit, in accordance with Section 3, below.  • IF the benefits check result in a copay greater than two hundred dollars ($200), Insulet, or its authorized partners, shall arrange for the shipment of one (1) Omnipod 5 Intro Kit, in accordance with Section 4, below.  • For the purpose of clarity, the term “copay” shall encompass any out-of-pocket expense for one (1) month’s supply of Pods, including any deductible, copays and other out-of-pocket expenses that the participant would have to disburse to procure said supply of Pods.  • Any copay assistance may not apply to a participant’s health plan’s deductible if prohibited by state law or by a health plan.  • In order to use the Omnipod 5 System in Automated Mode, the User must also procure a compatible CGM. This program does not include supply of a compatible CGM.Insulet reserves the right to change, amend or rescind this Program, in whole or in part, at any time.3. Copay CardShould participant be deemed eligible to receive an Omnipod 5 Copay Card, participant shall receive electronically one (1) Omnipod 5 Copay Card, valid for a single use, in the amount required for the participant to procure one (1) Omnipod 5 Intro Kit, which shall include:- One (1) Omnipod 5 Controller- Ten (10) Omnipod 5 Pods- One (1) Omnipod 5 User Guide- One (1) Controller charging cable4. Product DispenseShould participant be deemed eligible to receive a one-time dispense of Omnipod 5 Pods at no cost to them, Insulet, or its authorized partner, shall dispense one (1) Omnipod 5 Intro Kit, which shall include:- One (1) Omnipod 5 Controller- Ten (10) Omnipod 5 Pods- One (1) Omnipod 5 User Guide- One (1) Controller charging cableThe Omnipod 5 Intro Kit shall be delivered to the shipping address indicated by participant in their Acknowledgment Form. Any estimate date of delivery is given solely for participant’s information and does not constitute a warranty that the Intro Kit will be delivered on said date. Participant is responsible to provide an accurate delivery address, to receive shipment of the Intro Kit and to verify the content of the Intro Kit.

Omnipod DASH® 30-Day Free Trial Terms and Conditions

1. Program EligibilityEligibility criteria: Subject to program limitations and terms and conditions, the Omnipod DASH 30-day Free Trial Program (the “Program”) is open to patients who have a valid Omnipod DASH prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. The Program is open only to new Pod Therapy patients coming from multiple daily injections or tubed pumps only who have not previously used Omnipod® 5, Omnipod DASH or Omnipod Insulin Management System.This offer is not valid for participants whose Omnipod DASH prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs, or where prohibited by law. Participants on certain commercial insurance plans may not be eligible. This offer is only valid in the United States, Puerto Rico, and the U.S. territories. Please contact Insulet Customer Support at 1-800-591-3455 for details.2. Program DetailsWith this program, Participants may be eligible to receive a 30-day supply of Omnipod DASH products at no cost for them. Eligible participants have two (2) options, based on the following:• A participant shall sign the 30-day Omnipod DASH Free Trial Acknowledgement through the appropriate platform provided by Insulet’s pharmacy partner.• Once Insulet, or its pharmacy partner, has received the request, including a valid prescription for the Omnipod DASH Intro Kit and Omnipod DASH Pods, the participant’s benefits will be checked by Insulet or its pharmacy partner.  • If the benefits check results in a monthly copay equal to or below two hundred dollars ($200), then Insulet, or its pharmacy partner, shall issue a one-time only copay card to the participant, for a value equal to the out-of-pocket expenses the participant would have to pay for an Omnipod DASH 30-day initial shipment, in accordance with Section 3, below.  • If the benefits check result in a copay greater than two hundred dollars ($200), Insulet, or its authorized partners, shall arrange for the shipment of one (1) Omnipod DASH Intro Kit, in accordance with Section 4, below.  • For the purpose of clarity, the term “copay” shall encompass any out-of-pocket expense for one (1) month’s supply of Pods, including any deductible, copays and other out-of-pocket expenses t

[H1] Omnipod® 5 for Kids and Teens​

[IMG: Omnipod 5 Pod right no adhesive]

[IMG: Omnipod 5 Pod right no adhesive]

Pod shown without necessary adhesive.​

[H2] The best of both worlds
Omnipod 5 is the only tubeless automated insulin delivery device in the US cleared for type 1 diabetes ages 2+.The System integrates with a compatible glucose sensor to automatically increase, decrease, or pause insulin delivery to help protect against highs and lows, day and night.1.2Long gone are the days of choosing between automated insulin delivery and tubeless freedom. Now kids, teens, and their caregivers can have the best of both worlds, all in one.

[H2] Peace of mind for parents
Omnipod 5 is the System that’s always adjusting, so you don’t have to be. The Omnipod 5 Algorithm predicts glucose levels 60 minutes into the future and makes automatic insulin delivery adjustments to help manage glucose levels. ​

[IMG: Icon Stop Clock svg]

Clinical study participants showed improved time in range by 3.7 hours per day in children (2.6 hours per day in children ages 2-5.9 years) and 2.2 hours per day in adolescents and adults.1,2​

[IMG: Icon Lower A1C svg]

Clinical study participants experienced a reduction in A1C of 0.71% in children (0.5% in children ages 2-5.9 years) and 0.38% in adolescents and adults.1,2​

[IMG: Icon Stop Clock svg]

Clinical study participants reduced time in hypoglycemia by 4 minutes per day in children ages 2-5.9 and 13 minutes per day in adolescents and adults, while lows remained minimal in children ages 6-14.1,2​

In a 3-month clinical study, 3 cases of severe hypoglycemia and 1 case of diabetic ketoacidosis (DKA) were reported in children and adults/adolescents during Omnipod 5 System use. These cases were not related to automated insulin delivery malfunction.​

[H4] “Omnipod 5 is something that we know and we trust. It does what it's supposed to do when it's supposed to do it. It's a comfort, and it's a peace of mind for all of us.”
-Erik N., dad to Podder® Ben​

[H2] Tubeless freedom for kids
Omnipod 5 is the only tubeless automated insulin delivery system in the US, which means your child can focus less on type 1 diabetes and more on the important things – like just being a kid. ​

No multiple daily injections—Omnipod delivers insulin continuously for 3 days (up to 72 hours)Waterproof†—can be worn while swimming, bathing, or showering – no need to ever disconnect for daily activities§Tangle-proof—no tubes to get caught when playing with friends or going to soccer practice

†The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

§ Device components including the Pod, CGM transmitter, and CGM sensor may be affected by strong radiation or magnetic fields. Device components must be removed (and the Pod and CGM sensor should be disposed of) before X-ray, Magnetic Resonance Imaging (MRI), or Computed Tomography (CT) scan (or any similar test or procedure). In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to X-ray, MRI, or CT, treatment can damage these components. Check with your healthcare provider on Pod removal guidelines.

Discreet—small enough to be worn under clothing with the Omnipod 5 App that makes insulin delivery look like sending a text​Simplify mealtimes - The SmartBolus Calculator simplifies complicated math at meal and snack times ​Durable—ideal for competitive sports and active lifestyles​

[IMG: Omnipod Pod placement guide]

[IMG: Omnipod Pod placement guide]

[H2] Wear the Pod with ease
The Pod can be worn almost anywhere you’d give an insulin injection, which means there are plenty of options to suit your child’s preferences. ​Plus, unlike traditional insulin pumps, there’s no need to disconnect for activities like showering, swimming, or sports, which means no interruption in automated insulin delivery. ​
Pod Placement Guide

[H2] Check your coverage
Choose your preferred path to answer a few questions. Once complete, a member of the Omnipod Pharmacy support team** will reach out with your expected copay and free trial†† eligibility.​

[IMG: Icon Check Benefits]

[H4] I’d like to check my coverage
[H5] Find out your estimated copay

Check My Coverage

[IMG: Icon Free Trial]

[H4] I'd like a free trial of Omnipod††
[H5] Take the Pod for a test drive

Let's Go

[H2] Experience award-winning automation​

Omnipod 5 boasts outstanding design and engineering, recognized by the CES Innovation Awards in 2022.​ ​Using the Omnipod 5 algorithm, the Pod and a compatible CGM are in constant communication, enabling automatic insulin adjustments to help keep you in range.1,2​

[IMG: How Automated Insulin Delivery works infographic]

[IMG: How Automated Insulin Delivery works infographic]

[H3] Ready to get started?

Check my coverage

Risk Statement   The Omnipod 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older and individuals with type 2 diabetes ages 18 years and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, Admelog®, and Kirsty®.The Omnipod 5 Pump (Pod) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Omnipod 5 Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. SmartAdjust™ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values. The Omnipod 5 SmartBolus Calculator is intended to calculate a suggested bolus dose based on user-entered carbohydrates, most recent sensor glucose value (or blood glucose reading if using fingerstick), rate of change of the sensor glucose (if applicable), insulin on board (IOB), and programmable correction factor, insulin to carbohydrate ratio, and target glucose value.   WARNING: SmartAdjust technology should NOT be used by anyone under the age of 2 years old. SmartAdjust technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.The Omnipod 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod 5 System according to instructions, are taking hydroxyurea as it could lead to falsely elevated CGM values and result in over-delivery of insulin that can lead to severe hypoglycemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod 5 System, including alerts, alarms, and reminders. Device components including the Pod, CGM transmitter, and CGM sensor must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment. In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components. Visit www.omnipod.com/safety for additional important safety information.   WARNING: DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.1. Study in 80 people with T1D aged 2 -5.9 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in Target Glucose range (from CGM) for standard therapy vs Omnipod 5 = 57.2% vs. 68.1%. Average time in Target Glucose range (6AM-12AM) from CGM in standard therapy vs Omnipod 5 = 58.2% vs. 64.3%. Average time in Target Glucose range (12AM-6AM) from CGM in standard therapy vs. Omnipod 5 = 60.6% vs 82.4%. Average overnight time (12AM-6AM) with high blood glucose in adults/adolescents and children for standard therapy vs. Omnipod 5 = 32.1% vs. 20.7%; 42.2% vs. 20.7%. Average day time (6AM-12AM) with high blood glucose in adults/adolescents and children for standard therapy vs. Omnipod 5 = 32.6% vs. 26.1%; 46.4% vs. 33.4%. Median overnight time (12AM-6AM) with low blood glucose in adults/adolescents and children for standard therapy vs. Omnipod 5 = 2.07% vs. 0.82%; 0.78% vs. 0.78%. Median day time (6AM-12AM) with low blood glucose in adults/adolescents and children for standard therapy vs. Omnipod 5 = 1.91% vs. 1.08%; 1.17% vs. 1.62%. Average A1c in standard therapy vs. Omnipod 5 = 7.4% vs. 6.9%. SherrJL, et al. Diabetes Care (2022).  2. Study in 240 people with T1D aged 6 -70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in Target Glucose range (from CGM) for standard therapy vs Omnipod 5 in adults/adolescents and children = 64.7% vs. 73.9%; 52.5% vs. 68.0%. Average day time (6AM-12AM) in Target Glucose range (from CGM) in adults/adolescents and children for standard therapy vs Omnipod 5 = 64.8% vs. 72.5%; 51.5% vs. 64.6%. Average overnight (12AM-6AM) in Target Glucose range (from CGM) in adults/adolescents and children for standard therapy vs Omnipod 5 = 64.3% vs. 78.1%; 55.3% vs. 78.1%. Average time with high blood glucose overnight from CGM in standard therapy vs. Omnipod 5 = 38.4% vs. 16.9%. Average time with high blood during daytime from CGM in standard therapy vs. Omnipod 5 = 39.7% vs. 33.7%. Average time with low blood glucose overnight from CGM in standard therapy vs. Omnipod 5 = 3.41% vs. 2.13%. Average time with low blood glucose during daytime from CGM in standard therapy vs. Omnipod 5 = 3.44% vs. 2.57%. Average A1c in adults/adolescents and children, standard therapy vs. Omnipod 5 = 7.16% vs 6.78%; 7.67% vs 6.99%. Brown et al. Diabetes Care (2021).3. Pasquel FJ, et al. Presented at: ADA; June 21-24, 2024; Orlando, FL. Prospective pivotal trial in 305 participants with T2D aged 18-75 yrs. Study included a 14-day standard therapy (ST) phase followed by a 13-week Omnipod 5 hybrid closed-loop phase. Mean time <70 mg/dL as measured by CGM: ST = 0.2%, 3-mo Omnipod 5 = 0.2%, P<001. Mean time >180 mg/dL as measured by CGM: ST = 54%, 3-mo Omnipod 5 = 34%, P<0.001. Comparison is relative change.**ASPN Pharmacies and its dedicated staff power the Omnipod Pharmacy Support Program. The ASPN team is here for you to check your coverage and help coordinate fulfillment at your pharmacy of choice.

††Omnipod® 5 Intro Kit 30-Day TrialTerms and Conditions1. Program EligibilityEligibility criteria: Subject to program limitations and terms and conditions, the Omnipod 5 Intro Kit 30-day trial program (the “Program”) is open to patients who have a valid Omnipod 5 prescription as well as a compatible CGM prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. In order to be eligible, the patient’s eligible insurance plan must include coverage for Omnipod 5 Pods. The Program is open to new Pod Therapy patients coming from multiple daily injections or tubed pumps only who have not previously used Omnipod 5, Omnipod DASH® or Omnipod Insulin Management System.  This offer is not valid for participants whose Omnipod 5 or compatible CGM prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs. It is not valid for cash-paying participants or where prohibited by law. A participant is considered cash-paying where the participant has no insurance coverage for Omnipod 5 or where the participant has commercial or private insurance but Insulet determines in its sole discretion the participant is effectively uninsured because such coverage does not provide a material level of financial assistance for the cost of an Omnipod 5 prescription. Participants on certain commercial insurance plans may not be eligible. This offer is only valid in the United States, Puerto Rico, and the U.S. territories. Participants receiving their products through the Durable Medical Equipment or Pharmacy Durable Medical Equipment channel are not eligible to participate in the copay card program. Please contact Insulet Customer Support at 1-800-591-3455 for details.2. Program DetailsWith this program, Participants may be eligible to receive a limited supply of Omnipod 5 products at no cost for them. Eligible participants have two (2) options, based on the following: A participant shall sign the Omnipod® 5 Intro Kit 30-Day Trial Acknowledgement through the appropriate platform provided by Insulet. Once Insulet has received the request, the request shall be escalated to Insulet’s pharmacy partner, where a request for a prescription shall be sent to the participant’s healthcare professional. If a valid prescription is received, both for the Omnipod 5 Intro Kit and the Omnipod 5 Pods, the participant’s benefits will be checked by Insulet or its partners.a) IF the benefits check results in a monthly copay equal to or below two hundred dollars ($200), then Insulet shall issue a one-time only copay card to the participant, for a value equal to the out-of-pocket expenses the participant would have to pay for an Omnipod 5 Intro Kit, in accordance with Section 3, below. b) IF the benefits check result in a copay greater than two hundred dollars ($200), Insulet, or its authorized partners, shall arrange for the shipment of one (1) Omnipod 5 Intro Kit, in accordance with Section 4, below. c) For the purpose of clarity, the term “copay” shall encompass any out-of-pocket expense for one (1) month’s supply of Pods, including any deductible, copays and other out-of-pocket expenses that the participant would have to disburse to procure said supply of Pods. d) Any copay assistance may not apply to a participant’s health plan’s deductible if prohibited by state law or by a health plan. e) In order to use the Omnipod 5 System in Automated Mode, the User must also procure a compatible CGM. This program does not include supply of a compatible CGM. Insulet reserves the right to change, amend or rescind this Program, in whole or in part, at any time.  3. Copay C

[H1] What is Omnipod?

The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Personal Diabetes Manager and Controller are not waterproof.

[H2] Omnipod® gives you more with less
Omnipod provides continuous insulin delivery through a tubeless, waterproof* insulin pump called a Pod—all with no daily insulin injections. Get up to 3 days (72 hours) of continuous insulin delivery and freedom with these innovative features:Wearable: Place the Pod almost anywhere you’d normally injectWaterproof*: Take your insulin anywhere life takes you, even while swimmingTangle-proof: Forget the tubes of traditional insulin pumps

[H2] How Omnipod Works
Omnipod tubeless systems are made of two main components, the Pod and a smartphone-like PDM/Controller. The Pod is a small device that you fill with insulin and wear directly on your body. The Pod receives insulin delivery instructions from the Controller. It then delivers insulin into your body through a small, flexible tube called a cannula.​
Learn More

*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Personal Diabetes Manager and Controller are not waterproof.

[H2] #1 Prescribed Automated Insulin Delivery System1
1USA 2023, Data on file

Learn More

[IMG: Omnipod 5 Controller with Pod on the left]

[IMG: Omnipod 5 Controller with Pod on the left]

[H4] COMPATIBLE WITH

Image
[IMG: Dexcom G7]

Image
[IMG: Dexcom G6]

Image
[IMG: Libre Freestyle 2 Plus]
Pod and CGM sensors shown without the necessary adhesive. Dexcom G7 CGM Systems, Dexcom G6, and FreeStyle Libre 2 Plus Sensor sold separately and require a separate prescription.

[H2] Omnipod® 5
With Omnipod 5 Automated Insulin Delivery System, your diabetes devices are in sync without tubes to tie you down.The Omnipod 5 Algorithm automatically increases, decreases, or pauses insulin every 5 minutes, based on your customized target—helping to protect against highs and lows2-4Activity feature when enabled, reduces insulin delivery when glucose typically goes low, like when exercisingSmartBolus Calculator, the only AID system with a built-in bolus calculator that automatically incorporates your CGM value and trend, so you don’t have toCompatible with Dexcom G7 CGM Systems, Dexcom G6, and the FreeStyle Libre 2 Plus Sensor.You will still need to bolus for meals. With Omnipod 5, this is done with the Omnipod 5 App or Controller.The Omnipod 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older and type 2 diabetes mellitus in persons 18 years of age and older.Dexcom is in the process of discontinuing Dexcom G6 to focus on delivering the next generation of CGM. Omnipod 5 will continue to support integration with Dexcom G6 for as long as this sensor remains available. For more information, please visit www.dexcom.com or contact Dexcom support.
See All New Features

[H2] Omnipod DASH®
A tubeless, wireless insulin management system that lets you experience more freedom with fewer daily hassles. Wear the Pod for up to 3 days (72 hours) of continuous insulin delivery, without multiple daily injections. And the convenience doesn’t stop there, get it all through the pharmacy. Even the Personal Diabetes Manager (PDM) comes at no charge to you‡.
‡Omnipod DASH System customers will be eligible to receive one free PDM every four years with the purchase of Pods subject to certain conditions including, but not limited to, verification of insurance.

Omnipod DASH is cleared for anyone with insulin requiring diabetes.
Learn About Omnipod DASH

[IMG: DASH Pod Left No Adhesive 600x825]

[IMG: DASH Pod Left No Adhesive 600x825]

Pod shown without the necessary adhesive.

Omnipod 5 simplifies so much. It's almost like someone else is looking out for you.

April Blackwell
Sponsored Podder®

[H2] Like what you see?
Now that you’ve learned a little about Omnipod, you might be ready to take the next step. To get more information on whether Omnipod is right for you, connect with an Omnipod Specialist for more information. Or, get started with an Omnipod DASH or Omnipod 5 trial§.
Check your coverage

1. USA 2023, Data on file2. Brown S. et al. Diabetes Care (2021). Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Average time with low blood glucose in adults/adolescents and children, standard therapy vs 3-month Omnipod 5: 2.9% vs. 1.3%; 2.2% vs. 1.8%. Study funded by Insulet.3. Sherr JL, et al. Diabetes Care (2022). Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in very young children, standard therapy vs 3-month Omnipod 5: 39.4% vs. 29.5%. Average time with low blood glucose in very young children, standard therapy vs 3-month Omnipod 5: 3.43% vs. 2.46%. Study funded by Insulet.4. Pasquel FJ, et al. JAMA Network Open (2025). Prospective pivotal trial in 305 participants with T2D aged 18-75 yrs. Study included a 14-day standard therapy (ST) phase followed by a 13-week Omnipod 5 hybrid closed-loop phase. Mean time <70 mg/dL as measured by CGM: ST = 0.2%, 3-mo Omnipod 5 = 0.2%, P<001. Mean time >180 mg/dL as measured by CGM: ST = 54%, 3-mo Omnipod 5 = 34%, P<0.001. Comparison is relative change. §Omnipod DASH® 30-Day Free Trial  Terms and Conditions1. Program EligibilityEligibility criteria: Subject to program limitations and terms and conditions, the Omnipod DASH 30-day Free Trial Program (the “Program”) is open to patients who have a valid Omnipod DASH prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. The Program is open only to new Pod Therapy patients coming from multiple daily injections or tubed pumps only who have not previously used Omnipod® 5, Omnipod DASH or Omnipod Insulin Management System.This offer is not valid for participants whose Omnipod DASH prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs, or where prohibited by law. Participants on certain commercial insurance plans may not be eligible. This offer is only valid in the United States, Puerto Rico, and the U.S. territories. Please contact Insulet Customer Support at 1-800-591-3455 for details.2. Program DetailsWith this program, Participants may be eligible to receive a 30-day supply of Omnipod DASH products at no cost for them. Eligible participants have two (2) options, based on the following:• A participant shall sign the 30-day Omnipod DASH Free Trial Acknowledgement through the appropriate platform provided by Insulet’s pharmacy partner.  • Once Insulet, or its pharmacy partner, has received the request, including a valid prescription for the Omnipod DASH Intro Kit and Omnipod DASH Pods, the participant’s benefits will be checked by Insulet or its pharmacy partner.     • If the benefits check results in a monthly copay equal to or below two hundred dollars ($200), then Insulet, or its pharmacy partner, shall issue a one-time only copay card to the participant, for a value equal to the out-of-pocket expenses the participant would have to pay for an Omnipod DASH 30-day initial shipment, in accordance with Section 3, below.     • If the benefits check result in a copay greater than two hundred dollars ($200), Insulet, or its authorized partners, shall arrange for the shipment of one (1) Omnipod DASH Intro Kit, in accordance with Section 4, below.     • For the purpose of clarity, the term “copay” shall encompass any out-of-pocket expense for one (1) month’s supply of Pods, including any deductible, copays and other out-of-pocket expenses that the participant would have to disburse to procure said supply of Pods.     • Any copay assistance may not apply to a participant’s health plan’s deductible if prohibited by state law or by a health plan.Insulet reserves the right to change, amend or rescind this Program, in whole or in part, at any time.3. Copay CardShould participant be deemed eligible to receive an Omnipod DASH Copay Card, participant shall receive electronically one (1) Omnipod DASH Copay Card, valid for a single use, in the amount required for the participant to procure a 30-day supply of Omnipod DASH Pods at a participating pharmacy. In addition, Insulet’s pharmacy partners shall ship, at no cost to participant, one (1) Omnipod DASH Starter Kit, which shall include:• One (1) Omnipod DASH Personal Diabetes Manager (PDM)  • One (1) Omnipod DASH User Guide  • One (1) PDM charging cableThe Omnipod DASH Starter Kit shall be delivered to the shipping address indicated by participant in their Acknowledgment Form. Any estimate date of delivery is given solely for participant’s information and does not constitute a warranty that the Starter Kit will be delivered on said date. Participant is responsible to provide an accurate delivery address, to receive shipment of the Starter Kit and to verify the content of the Starter Kit.4. Product DispenseShould participant be deemed eligible to receive a one-time dispense of Omnipod DASH Pods at no cost to them, Insulet, or its authorized partner, shall dispense one (1) Omnipod DASH Intro Kit, which shall include:• One (1) Omnipod DASH PDM  • Eleven (11) Omnipod DASH Pods  • One (1) Omnipod DASH User Guide  • One (1) PDM charging cableThe Omnipod DASH Intro Kit shall be delivered to the shipping address indicated by participant in their Acknowledgment Form. Any estimate date of delivery is given solely for participant’s information and does not constitute a warranty that the Intro Kit will be delivered on said date. Participant is responsible to provide an accurate delivery address, to receive shipment of the Intro Kit and to verify the content of the Intro Kit. §Omnipod® 5 Intro Kit 30-Day TrialTerms and Conditions1. Program EligibilityEligibility criteria: Subject to program limitations and terms and conditions, the Omnipod 5 Intro Kit 30-day trial program (the “Program”) is open to patients who have a valid Omnipod 5 prescription as well as a compatible CGM prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. In order to be eligible, the patient’s eligible insurance plan must include coverage for Omnipod 5 Pods. The Program is open to new Pod Therapy patients coming from multiple daily injections or tubed pumps only who have not previously used Omnipod 5, Omnipod DASH® or Omnipod Insulin Management System.This offer is not valid for participants whose Omnipod 5 or compatible CGM prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs. It is not valid for cash-paying participants or where prohibited by law. A participant is considered cash-paying where the participant has no insurance coverage for Omnipod 5 or where the participant has commercial or private insurance but Insulet determines in its sole discretion the participant is effectively uninsured because such coverage does not provide a material level of financial assistance for the cost of an Omnipod 5 prescription. Participants on certain commercial insurance plans may not be eligible. This offer is only valid in the United States, Puerto Rico, and the U.S. territories. Participants receiving their products through the Durable Medical Equipment or Pharmacy Durable Medical Equipment channel are not eligible to participate in the copay card program. Please contact Insulet Customer Support at 1-800-591-3455 for details.2. Program DetailsWith this program, Participants may be eligible to receive a limited supply of Omnipod 5 products at no cost for them. Eligible participants have two (2) options, based on the following:• A participant shall sign the Omnipod® 5 Intro Kit 30-Day Trial Acknowledgement through the appropriate platform provided by Insulet.• Once Insulet has received the request, the request shall be escalated to Insulet’s pharmacy partner, where a request for a prescription shall be sent to the participant’s healthcare professional. If a valid prescription is received, both for the Omnipod 5 Intro Kit and the Omnipod 5 Pods, the participant’s benefits will be checked by Insulet or its partners.   • IF the benefits check results in a monthly copay equal to or below two hundred dollars ($200), then Insulet shall issue a one-time only copay card to the participant, for a value equal to the out-of-pocket expenses the participant would have to pay for an Omnipod 5 Intro Kit, in accordance with Section 3, below.   • IF the benefits check result in a copay greater than two hundred dollars ($200), Insulet, or its authorized partners, shall arrange for the shipment of one (1) Omnipod 5 Intro Kit, in accordance with Section 4, below.   • For the purpose of clarity, the term “copay” shall encompass any out-of-pocket expense for one (1) month’s supply of Pods, including any deductible, copays and other out-of-pocket expenses that the participant would have to disburse to procure said supply of Pods.   • Any copay assistance may not apply to a participant’s health plan’s deductible if prohibited by state law or by a health plan.   • In order to use the Omnipod 5 System in Automated Mode, the User must also procure a compatible CGM. This program does not include supply of a compatible CGM.Insulet reserves the right to change, amend or rescind this Program, in whole or in part, at any time.3. Copay CardShould participant be deemed eligible to receive an Omnipod 5 Copay Card, participant shall receive electronically one (1) Omnipod 5 Copay Card, valid for a single use, in the amount required for the participant to procure one (1) Omnipod 5 Intro Kit, which shall include:• One (1) Omnipod 5 Controller• Ten (10) Omnipod 5 Pods• One (1) Omnipod 5 User Guide• One (1) Controller charging cable4. Product DispenseShould participant be deemed eligible to receive a one-time dispense of Omnipod 5 Pods at no cost to them, Insulet, or its authorized partner, shall dispense one (1) Omnipod 5 Intro Kit, which shall include:• One (1) Omnipod 5 Controller• Ten (10) Omnipod 5 Pods• One (1) Omnipod 5 User Guide• One (1) Controller charging cableThe Omnipod 5 Intro Kit shall be delivered to the shipping address indicated by participant in their Acknowledgment Form. Any estimate date of delivery is given solely for participant’s information and does not constitute a warranty th

[H1] Is Omnipod® Right for me?

[H2] Omnipod helps thousands of people simplify life with diabetes
Omnipod* was designed to simplify life with diabetes. From parents struggling to manage their child’s insulin needs, to adults who’ve written off pumps altogether, Omnipod can simplify life with 3 days (up to 72 hours) of continuous, tubeless insulin delivery with no multiple daily injections.
*Omnipod® 5 is indicated for people with type 1 diabetes, 2 years of age and older and type 2 diabetes ages 18 years and older. Omnipod DASH® is indicated for anyone with insulin-requiring diabetes.

Omnipod for Type 1 Diabetes

Omnipod for Type 2 Diabetes

[H2] Covered by most insurance plans
Majority of commercially insured Omnipod 5 users pay less than $30 per month† at the pharmacy with more than 40% paying $0 out of pocket‡.Omnipod is also covered under Medicare Part D plans through your pharmacy.Learn more about the costs and coverage of Omnipod, and see if you're eligible for a free trial◊.
Costs and Coverage

[H3] Omnipod for Kids
The Pod lets your child focus less on type 1 diabetes and more on the important things – like just being a kid! Discreet—small enough to be worn under clothing with the Omnipod 5 App that makes insulin delivery look like sending a text​ ​Waterproof*– it can be worn while swimming, bathing, or showering – no need to disconnect Durable—ideal for competitive sports and active lifestylesLong gone are the days of choosing between automated insulin delivery and tubeless freedom. Now kids, teens, and their caregivers can have the best of both worlds, all in one.
*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Personal Diabetes Manager/Controller is not waterproof.
Omnipod for Kids

[H2] 90% would recommend Omnipod to a friend§
90% of study participants agreed that they would recommend Omnipod 5 to a friend or family member§.

Hear What Users Say

It creates harmony in your life.

Zac
Omnipod 5 user

[H2] Ready to take the next step?
Both Omnipod 5 Automated Insulin Delivery System and Omnipod DASH are game-changing systems for insulin delivery. See if you’re covered for either one with a no-commitment benefits check, we’ll do the leg work for you. While you’re at it, you can check your eligibility for the free 30-day trial◊.
Check My Coverage

§Pasquel FJ, et al. JAMA Network Open (2025). Prospective pivotal trial in 305 participants with T2D aged 18-75 yrs. Study included a 14-day standard therapy (ST) phase followed by a 13-week Omnipod 5 hybrid closed-loop phase. 78% of participants strongly agreed and 12% agreed a little that they would recommend Omnipod 5 to family member or friend.†Among All Paid Omnipod 5 G7G6 and Libre2Plus Pods Commercial  Claims from January 2025 to December 2025. Includes benefits and offerings available through Insulet, such as the copay card program. Actual co-pay amount depends on patient’s health plan and coverage, they may fluctuate and be higher or lower than the advertised amount on a monthly basis.  Source: IQVIA OPC Library. RF-012026-00067  ‡Among All Paid Omnipod 5 G7G6 and Libre2Plus Pods Commercial and Medicare Claims from January 2025 to December 2025. Includes benefits and offerings available through Insulet, such as the copay card program. Actual co-pay amount depends on patient’s health plan and coverage, they may fluctuate and be higher or lower than the advertised amount on a monthly basis.  Source: IQVIA OPC Library. RF-012026-00067.

◊Omnipod® 5 Intro Kit 30-Day Trial Terms and Conditions

1. Program EligibilityEligibility criteria: Subject to program limitations and terms and conditions, the Omnipod 5 Intro Kit 30-day trial program (the “Program”) is open to patients who have a valid Omnipod 5 prescription as well as a compatible CGM prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. In order to be eligible, the patient’s eligible insurance plan must include coverage for Omnipod 5 Pods. The Program is open to new Pod Therapy patients coming from multiple daily injections or tubed pumps only who have not previously used Omnipod 5, Omnipod DASH® or Omnipod Insulin Management System. This offer is not valid for participants whose Omnipod 5 or compatible CGM prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs. It is not valid for cash-paying participants or where prohibited by law. A participant is considered cash-paying where the participant has no insurance coverage for Omnipod 5 or where the participant has commercial or private insurance but Insulet determines in its sole discretion the participant is effectively uninsured because such coverage does not provide a material level of financial assistance for the cost of an Omnipod 5 prescription. Participants on certain commercial insurance plans may not be eligible. This offer is only valid in the United States, Puerto Rico, and the U.S. territories. Participants receiving their products through the Durable Medical Equipment or Pharmacy Durable Medical Equipment channel are not eligible to participate in the copay card program. Please contact Insulet Customer Support at 1-800-591-3455 for details.2. Program DetailsWith this program, Participants may be eligible to receive a limited supply of Omnipod 5 products at no cost for them. Eligible participants have two (2) options, based on the following:• A participant shall sign the Omnipod® 5 Intro Kit 30-Day Trial Acknowledgement through the appropriate platform provided by Insulet.• Once Insulet has received the request, the request shall be escalated to Insulet’s pharmacy partner, where a request for a prescription shall be sent to the participant’s healthcare professional. If a valid prescription is received, both for the Omnipod 5 Intro Kit and the Omnipod 5 Pods, the participant’s benefits will be checked by Insulet or its partners.• IF the benefits check results in a monthly copay equal to or below two hundred dollars ($200), then Insulet shall issue a one-time only copay card to the participant, for a value equal to the out-of-pocket expenses the participant would have to pay for an Omnipod 5 Intro Kit, in accordance with Section 3, below.• IF the benefits check result in a copay greater than two hundred dollars ($200), Insulet, or its authorized partners, shall arrange for the shipment of one (1) Omnipod 5 Intro Kit, in accordance with Section 4, below.• For the purpose of clarity, the term “copay” shall encompass any out-of-pocket expense for one (1) month’s supply of Pods, including any deductible, copays and other out-of-pocket expenses that the participant would have to disburse to procure said supply of Pods.• Any copay assistance may not apply to a participant’s health plan’s deductible if prohibited by state law or by a health plan.• In order to use the Omnipod 5 System in Automated Mode, the User must also procure a compatible CGM. This program does not include supply of a compatible CGM. Insulet reserves the right to change, amend or rescind this Program, in whole or in part, at any time.3. Copay CardShould participant be deemed eligible to receive an Omnipod 5 Copay Card, participant shall receive electronically one (1) Omnipod 5 Copay Card, valid for a single use, in the amount required for the participant to procure one (1) Omnipod 5 Intro Kit, which shall include:- One (1) Omnipod 5 Controller- Ten (10) Omnipod 5 Pods- One (1) Omnipod 5 User Guide- One (1) Controller charging cable4. Product Dispense Should participant be deemed eligible to receive a one-time dispense of Omnipod 5 Pods at no cost to them, Insulet, or its authorized partner, shall dispense one (1) Omnipod 5 Intro Kit, which shall include:- One (1) Omnipod 5 Controller - Ten (10) Omnipod 5 Pods - One (1) Omnipod 5 User Guide - One (1) Controller charging cable The Omnipod 5 Intro Kit shall be delivered to the shipping address indicated by participant in their Acknowledgment Form. Any estimate date of delivery is given solely for participant’s information and does not constitute a warranty that the Intro Kit will be delivered on said date. Participant is responsible to provide an accurate delivery address, to receive shipment of the Intro Kit and to verify the content of the Intro Kit.

Omnipod® DASH 30-Day Trial Terms and Conditions

1. Program EligibilityEligibility criteria: Subject to program limitations and terms and conditions, the Omnipod DASH 30-day Free Trial Program (the “Program”) is open to patients who have a valid Omnipod DASH prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. The Program is open only to new Pod Therapy patients coming from multiple daily injections or tubed pumps only who have not previously used Omnipod® 5, Omnipod DASH or Omnipod Insulin Management System.This offer is not valid for participants whose Omnipod DASH prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs, or where prohibited by law. Participants on certain commercial insurance plans may not be eligible. This offer is only valid in the United States, Puerto Rico, and the U.S. territories. Please contact Insulet Customer Support at 1-800-591-3455 for details.2. Program DetailsWith this program, Participants may be eligible to receive a 30-day supply of Omnipod DASH products at no cost for them. Eligible participants have two (2) options, based on the following:• A participant shall sign the 30-day Omnipod DASH Free Trial Acknowledgement through the appropriate platform provided by Insulet’s pharmacy partner. • Once Insulet, or its pharmacy partner, has received the request, including a valid prescription for the Omnipod DASH Intro Kit and Omnipod DASH Pods, the participant’s benefits will be checked by Insulet or its pharmacy partner. • If the benefits check results in a monthly copay equal to or below two hundred dollars ($200), then Insulet, or its pharmacy partner, shall issue a one-time only copay card to the participant, for a value equal to the out-of-pocket expenses the participant would have to pay for an Omnipod DASH 30-day initial shipment, in accordance with Section 3, below. • If the benefits check result in a copay greater than two hundred dollars ($200), Insulet, or its authorized partners, shall arrange for the shipment of one (1) Omnipod DASH Intro Kit, in accordance with Section 4, below. • For the purpose of clarity, the term “copay” shall encompass any out-of-pocket expense for one (1) month’s supply of Pods, including any deductible, copays and other out-of-pocket expenses that the participant would have to disburse to procure said supply of Pods. • Any copay assistance may not apply to a participant’s health plan’s deductible if prohibited by state law or by a health plan.Insulet reserves the right to change, amend or rescind this Program, in whole or in part, at any time.3. Copay CardShould participant be deemed eligible to receive an Omnipod DASH Copay Card, participant shall receive electronically one (1) Omnipod DASH Copay Card, valid for a single use, in the amount required for the participant to procure a 30-day supply of Omnipod DASH Pods at a participating pharmacy. In addition, Insulet’s pharmacy partners shall ship, at no cost to participant, one (1) Omnipod DASH Starter Kit, which shall include:- One (1) Omnipod DASH Personal Diabetes Manager (PDM) - One (1) Omnipod DASH User Guide - One (1) PDM charging cable The Omnipod DASH Starter Kit shall be delivered to the shipping address indicated by participant in their Acknowledgment Form. Any estimate date of delivery is given solely for participant’s information and does not constitute a warranty that the Starter Kit will be delivered on said date. Participant is responsible to provide an accurate delivery address, to receive shipment of the Starter Kit and to verify the content of the Starter Kit.4. Product DispenseShould participant be deemed eligible to receive a one-time dispense of Omnipod DASH Pods at no cost to them, Insulet, or its authorized partner, shall dispense one (1) Omnipod DASH Intro Kit, which shall include:- One (1) Omnipod DASH PDM - Eleven (11) Omnipod DASH Pods - One (1) Omnipod DASH User Guide - One (1) PDM charging cable The Omnipod DASH Intro Kit shall be delivered to the shipping address indicated by participant in their Acknowledgment Form. Any estimate date of delivery is given solely for participant’s information and does not constitute a warranty that the Intro Kit will be delivered on said date. Participant is responsible to provide an accurate delivery address, to receive shipment of the Intro Kit and to verify the content of the Intro Kit.Risk StatementThe Omnipod 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older and type 2 diabetes mellitus in persons 18 years of age and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, Admelog®, and Kirsty®. The Omnipod 5 ACE Pump (Pod) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Omnipod 5 ACE Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. SmartAdjust™ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values.The Omnipod 5 SmartBolus Calculator is intended to calculate a suggested bolus dose based on user-entered carbohydrates, most recent sensor glucose value (or blood glucose reading if using fingerstick), rate of change of the sensor glucose (if applicable), insulin on board (IOB), and programmable correction factor, insulin to carbohydrate ratio, and target glucose value.WARNING: SmartAdjust technology should NOT be used by anyone under the age of 2 years old. SmartAdjust technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.The Omnipod 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod 5 System according to instru